In animal models of DN, several agonists of NHRs, including the vitamin D receptor (VDR) [7], [8], the farnesoid X receptor (FXR) [9], and the estrogen receptor (ER) [10] have been reported to have potential suppressive effects on the progression of DN. This evidence concerns the gene ESR1 and liver dysplastic nodule.